Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ATTRACT - ArTificial inTelligence-based RAdiogenomics in Colon Tumors

NCT06108310 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT06108310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06108310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ATTRACT - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Unknown status
Start date
January 2, 2021
Completion date
December 31, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colon cancer stage ii, colon cancer stage iii